Cite

HARVARD Citation

    Merdjan, H. et al. (2017). Phase 1 Study Assessing the Pharmacokinetic Profile and Safety of Avibactam in Patients With Renal Impairment. Journal of clinical pharmacology. pp. 211-218. [Online]. 
  
Back to record